IND
Indivior
Stock
Stock
ISIN: GB00BN4HT335
Ticker: INDV
GB00BN4HT335
INDV
Price
Price
CHART BY
Frequently asked questions
What is Indivior's market capitalization?
The market capitalization of Indivior is $1.40B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Indivior?
Indivior's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.228. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Indivior's stock?
Currently, 7 analysts cover Indivior's stock, with a consensus target price of $14.90. Analyst ratings provide insights into the stock's expected performance.
What is Indivior's revenue over the trailing twelve months?
Over the trailing twelve months, Indivior reported a revenue of $1.17B.
What is the EBITDA for Indivior?
Indivior's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $306.09M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Indivior?
Indivior has a free cash flow of $134.02M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Indivior have, and what sector and industry does it belong to?
Indivior employs approximately 1,051 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Indivior's shares?
The free float of Indivior is 109.93M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.40B
- EPS (TTM)
- -$0.228
- Free Float
- 109.93M
- Revenue (TTM)
- $1.17B
- EBITDA (TTM)
- $306.09M
- Free Cashflow (TTM)
- $134.02M
Pricing
- 1D span
- $11.11$11.60
- 52W span
- $7.33$18.55
Analyst Ratings
The price target is $14.90 and the stock is covered by 7 analysts.
Buy
7
Hold
0
Sell
0
Information
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
- Employees
- 1,051
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- GB00BN4HT335
- Primary Ticker
- INDV
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet